Botulinum toxin A injection for post-stroke upper limb spasticity and rehabilitation practices from centers across Asian countries by Raymond L. Rosales, Raymond L. Rosales, Nicholas V. C. Chia, Witsanu Kumthornthip, Khean Jin Goh, Choon Soon Mak, Keng He Kong, Yee Sien Ng, Li Wei Chou, M. Jeanne Flordelis, Thuy Do, Pascal Maisonobe, Leonard S. W. Li, Areerat Suputtitada, Areerat Suputtitada

Subjects: Get full text

Clinical presentation of patients with lower limb spasticity undergoing routine treatment with botulinum toxin: baseline findings from an international observational study by Alberto Esquenazi, Richard D. Zorowitz, Stephen Ashford, Pascal Maisonobe, Simon Page, Jorge Jacinto

Subjects: Get full text

ULIS (Upper Limb International Spasticity), a 10-year Odyssey: An international, multicentric, longitudinal cohort of person-centered spasticity management in real-life practice by Lynne Turner-Stokes, Klemens Fheodoroff, Jorge Jacinto, Pascal Maisonobe, Stephen Ashford

Subjects: “…botulinum toxin…”
Get full text

The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study by Patricia Khan, Marcelo Riberto, João Amaury Frances, Regina Chueire, Ana Cristina Ferreira Garcia Amorim, Denise Xerez, Tae Mo Chung, Lucia Helena Costa Mercuri, Alexandre Luiz Longo, Sérgio Lianza, Pascal Maisonobe, Viviane C. Ruiz-Schutz

“…Botulinum toxin type A (BoNT-A) is an effective treatment for post-stroke spasticity; however, some patients cannot access treatment until ≥1 year post-stroke. …”
Get full text

Factors Influencing Goal Attainment in Patients with Post-Stroke Upper Limb Spasticity Following Treatment with Botulinum Toxin A in Real-Life Clinical Practice: Sub-Analyses from the Upper Limb International Spasticity (ULIS)-II Study by Klemens Fheodoroff, Stephen Ashford, Jorge Jacinto, Pascal Maisonobe, Jovita Balcaitiene, Lynne Turner-Stokes

Subjects: Get full text

Early AbobotulinumtoxinA (Dysport®) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study by Raymond L Rosales, Jovita Balcaitiene, Hugues Berard, Pascal Maisonobe, Khean Jin Goh, Witsanu Kumthornthip, Mazlina Mazlan, Lydia Abdul Latif, Mary Mildred D. Delos Santos, Chayaporn Chotiyarnwong, Phakamas Tanvijit, Odessa Nuez, Keng He Kong

Subjects: Get full text

Post Hoc Subgroup Analysis of the BCause Study Assessing the Effect of AbobotulinumtoxinA on Post-Stroke Shoulder Pain in Adults by Marcelo Riberto, João Amaury Frances, Regina Chueire, Ana Cristina Ferreira Garcia Amorim, Denise Xerez, Tae Mo Chung, Lucia Helena Costa Mercuri, Sérgio Lianza, Eduardo Carvalho de Melo Rocha, Pascal Maisonobe, Thais Cuperman-Pohl, Patricia Khan

“…Botulinum toxin type A is approved for the focal treatment of spasticity; however, the effectiveness of abobotulinumtoxinA (aboBoNT-A) in patients with shoulder pain who have set reduced pain as a treatment goal is understudied. …”
Get full text